Sinus Dynamics Introduces Medicated Liquid Gel for Use with Exclusive NasaTouch™ Atomizer to Treat Nasal Allergies and Acute/Chronic Sinusitis
Sinus Dynamics™ is a national compounding pharmacy dedicated to providing relief of sinusitis symptoms though the use of cutting edge technology and customized compounded medications. Recently, they have begun dispensing sinus medications, including antibiotics, antifungals and anti-inflammatories in a liquid gel form - which are administered utilizing an atomizing device.
The NasaTouch™ is an intranasal liquid delivery atomizer. It administers the liquid gel through the nasal openings depositing the content directly into the nasal and sinus regions. Once the liquid gel enters the nasal openings it will coat the lining of the nasal cavities making it much easier for the cilia to move the medication into the infected sinuses. In addition to allowing for deeper penetration of the medication, it also provides a longer contact time resulting in a slower release of the medication into the delicate tissue.
The NasaTouch™ atomizer utilizes the power of positive pressure to propel the liquid gel for deep penetration within the nasal and sinus cavities. The NasaTouch™ atomizer has the ability to produce a 6.0 micron sized particle enabling the medication to pass through highly congested areas and easily reach the infected sinuses. The NasaTouch™ holds 15 mL of liquid gel and can atomize 2 mL in 30 seconds, making it the fastest treatment option that Sinus Dynamics offers. It is easy to use, lightweight and portable and features a separate collection chamber to catch discharge, thereby eliminating the risk of contaminating the medication chamber. The NasaTouch™ atomizer is offered exclusively by Sinus Dynamics, a division of
Sinus Dynamics™ is contracted by over 14,000 insurance companies across the nation affording patients the ability to receive treatment for little to no cost. After providing treatment to over 35,000 sinus sufferers, Sinus Dynamics has become the leading force in the treatment of sinusitis and sinus related problems. Clinical studies have shown that 82.9% of patients treated with nebulized or atomized antibiotics with a mean particle diameter of 3.2 microns had a “good” or “excellent” response (referenced from the Scheinberg Study). For more information regarding the NasaTouch™ atomizing device and medicated liquid gels please contact:
SINUS DYNAMICS: 1-877-447-4276
or you can contact us through our website:
http://www.sinusdynamics.com/
###
Read the full story at http://www.prweb.com/releases/2011/6/prweb8583415.htm



A.M. Best Downgrades Ratings of American Agricultural Insurance Company
Advisor News
- The modern advisor: Merging income, insurance, and investments
- Financial shocks, caregiving gaps and inflation pressures persist
- Americans unprepared for increased longevity
- More investors will seek comprehensive financial planning
- Midlife planning for women: why it matters and how advisors should adapt
More Advisor NewsAnnuity News
- LIMRA: Annuity sales notch 10th consecutive $100B+ quarter
- AIG to sell remaining shares in Corebridge Financial
- Corebridge Financial, Equitable Holdings post Q1 earnings as merger looms
- AM Best Assigns Credit Ratings to Calix Re Limited
- Transamerica introduces new RILA with optional income features
More Annuity NewsHealth/Employee Benefits News
- Arizona's Medicaid, AHCCCS, undergoes huge changes
- Rob Schofield: NC’s new Medicaid ‘compromise’ comes at a cost
- We have to stop this with our votes | RODNEY WALKER
- MCCLELLAN INTRODUCES BILL TO HELP VIRGINIANS KEEP THEIR MEDICAID COVERAGE
- The Spine of Justice Roberts
More Health/Employee Benefits NewsLife Insurance News
- 2025 Insurance Abstracts
- AM Best Assigns Credit Ratings to Tokio Marine Newa Insurance Co., Ltd.
- Earnings roundup: Prudential works to save ‘unique’ Japanese market
- How life insurance became a living-benefits strategy
- Financial Focus : Keep your beneficiary choices up to date
More Life Insurance News